DiaMedica Therapeutics Inc. (DMAC) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$7,170
Total Return
-28.30%
CAGR
-6.44%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.99% |
| Median | +0.25% |
| Best | +100.62% |
| Worst | -58.23% |
| % of Windows Positive | 50.2% |
1-Year (252 Trading Days)
| Average | +35.13% |
| Median | +47.26% |
| Best | +209.45% |
| Worst | -74.86% |
| % of Windows Positive | 72.4% |
3-Year (756 Trading Days)
| Average | +183.66% |
| Median | +115.41% |
| Best | +699.11% |
| Worst | -73.94% |
| % of Windows Positive | 89.0% |
Risk Metrics
| Maximum Drawdown | -87.68% |
| Average Drawdown | -58.30% |
| Drawdown Duration | 1128 Trading Days |
| Sortino Ratio | 0.45 |
| Calmar Ratio | -0.07 |
| CVaR (5%) | -9.94% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -29.02% (-55.65% ann.) | $2902.01 | $0.00 | $0.00 | $0.00 |
| 2025 | +46.59% | +$4659.30 | $0.00 | $0.00 | $0.00 |
| 2024 | +91.20% | +$9119.72 | $0.00 | $0.00 | $0.00 |
| 2023 | +79.74% | +$7973.55 | $0.00 | $0.00 | $0.00 |
| 2022 | -57.64% | $5763.81 | $0.00 | $0.00 | $0.00 |
| 2021 | -63.21% | $6321.50 | $0.00 | $0.00 | $0.00 |
| 2020 | +109.07% | +$10907.22 | $0.00 | $0.00 | $0.00 |
| 2019 | +66.67% | +$6666.67 | $0.00 | $0.00 | $0.00 |
| 2018 | -41.80% | $4180.00 | $0.00 | $0.00 | $0.00 |
| 2017 | +127.69% | +$12768.67 | $0.00 | $0.00 | $0.00 |
| 2016 | +15.58% | +$1557.90 | $0.00 | $0.00 | $0.00 |
| 2015 | +90.00% | +$9000.00 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -32.98% (-96.66% ann.) | $3297.59 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 18, 2014 – February 19, 2020 | +260.59% | +27.65% | +$26058.98 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -58.75% | -100.00% | $5875.00 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +92.00% | +185.65% | +$9200.00 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.57% | -12.92% | $1357.14 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -67.11% | -69.30% | $6711.23 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +259.50% | +99.44% | +$25950.42 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +36.80% | +20.17% | +$3680.38 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.